Pharmacodynamic profile
Levomilnacipran potently inhibits serotonin (5-HT) and norepinephrine reuptake (IC50=16-19 nM
and 11 nM, respectively)*1
Greater reuptake inhibition of norepinephrine over serotonin was shown in vitro1
The clinical significance is unknown
Levomilnacipran lacks significant affinity for any other receptors, ion channels, or transporters
tested in vitro, including serotonergic (5HT1-7), α- and β- adrenergic, muscarinic, or histaminergic
receptors and Ca2+, Na+, K+, or Cl- channels1
Pharmacodynamic profileLevomilnacipran potently inhibits serotonin (5-HT) and norepinephrine reuptake (IC50=16-19 nMand 11 nM, respectively)*1Greater reuptake inhibition of norepinephrine over serotonin was shown in vitro1The clinical significance is unknownLevomilnacipran lacks significant affinity for any other receptors, ion channels, or transporterstested in vitro, including serotonergic (5HT1-7), α- and β- adrenergic, muscarinic, or histaminergicreceptors and Ca2+, Na+, K+, or Cl- channels1
การแปล กรุณารอสักครู่..